Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

American Pharmaceutical Partners to Report 2005 Second Quarter Financial Results and Host Conference Call on July 22, 2005

Posted on: Thursday, 7 July 2005, 09:01 CDT

SCHAUMBURG, Ill., July 7 /PRNewswire-FirstCall/ -- American Pharmaceutical Partners, Inc. announced today that it will release its 2005 second quarter financial results before the market opens on Friday, July 22, 2005. The company also said that senior management will host an investor conference call that same day at 10:00 a.m. Eastern to review the company's financial results and operations.

The conference call will be available to interested parties through a live audio Internet broadcast at http://www.appdrugs.com/ and http://www.earnings.com/. The call will also be archived and accessible at both sites for one year.

About American Pharmaceutical Partners, Inc.

American Pharmaceutical Partners, Inc. is a specialty drug company that develops, manufactures and markets injectable pharmaceutical products, focusing on the oncology, anti-infective and critical care markets. Abraxis Oncology, the proprietary division of APP, is devoted entirely to developing and promoting innovative, next-generation cancer therapies such as ABRAXANE(TM), recently launched for the treatment of metastatic breast cancer. For more information, visit APP's website at http://www.appdrugs.com/ and http://www.abraxisoncology.com/.

Contacts: American Pharmaceutical Partners, Inc. Nicole Williams Executive Vice President & CFO (847) 969-2700 Robert Jaffe/Rob Whetstone PondelWilkinson Inc. (310) 279-5980

American Pharmaceutical Partners, Inc.

CONTACT: Nicole Williams, Executive Vice President & CFO of AmericanPharmaceutical Partners, Inc., +1-847-969-2700; or Robert Jaffe, orRob Whetstone, both of PondelWilkinson Inc., +1-310-279-5980, for AmericanPharmaceutical Partners, Inc.

Web site: http://www.earnings.com/

Web site: http://www.appdrugs.com/http://www.abraxisoncology.com/


Source: PRNewswire-FirstCall

More News in this Category


Related Articles



Rating: 2.7 / 5 (3 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required

redOrbit Friends